SMOLDERING MULTIPLE MYELOMA
Clinical trials for SMOLDERING MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new SMOLDERING MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for SMOLDERING MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Bone drug trial aims to stop precancer from turning deadly
Prevention CompletedThis study tested whether denosumab, a medication that strengthens bones, could reduce the risk of smoldering multiple myeloma progressing to active cancer. Twenty adults with this precancerous condition received monthly injections for one year. Researchers monitored whether the …
Matched conditions: SMOLDERING MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Prevention
Last updated Apr 03, 2026 14:43 UTC
-
Scientists test scans to spot cancer before it strikes
Knowledge-focused CompletedThis study aimed to test and compare three different types of advanced imaging scans to see if they could better detect when early, pre-cancerous blood conditions progress to full multiple myeloma. It enrolled 31 adults already diagnosed with either the pre-cancerous conditions (…
Matched conditions: SMOLDERING MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Apr 04, 2026 00:35 UTC
-
Researchers dig into medical records to map the hidden path of a silent blood cancer
Knowledge-focused CompletedThis study looked back at the medical records of 431 people diagnosed with smoldering multiple myeloma, a pre-cancerous blood condition. The goal was to understand how the disease behaves in real life, identify which patients are at higher risk of it turning into active cancer, a…
Matched conditions: SMOLDERING MULTIPLE MYELOMA
Sponsor: Janssen-Cilag Ltd. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC